| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 2 securities · may seek to influence control | ||||||
|
Ultralife Corp
13D/A
ULBI · 903899102
|
40.3% |
10/29/2026
Event 10/27/2026
|
||||
| Whitmore Bradford T | 40.3% | |||||
| Sunray I, LLC | 26.7% | |||||
| Whitmore Holdings, LLC | 12.3% | |||||
| Zistar Management, LLC | 26.7% | |||||
| Bradford Whitmore Trust | 39.0% | |||||
|
Solesence, Inc.
13D/A
SLSN · 630079101
|
71.0% |
6/2/2025
Event 5/29/2025
|
||||
| Whitmore Bradford T | 71.0% | |||||
| Grace Investments LP | 0.9% | |||||
| Inv-GP, LLC | 0.9% | |||||
| Mobcat, LLC | 0.9% | |||||
| Strandler, LLC | 43.3% | |||||
| Whitmore Holdings, LLC | 70.9% | |||||
| Bradford Whitmore Trust | 70.9% | |||||
| Schedule 13G · 1 security · passive | ||||||
|
Clearside Biomedical, Inc.
13G/A
CLSD · 185063104
|
8.6% |
3/4/2025
Event 12/31/2024
|
||||
| Whitmore Bradford T | 8.6% | |||||
| Grace Brothers LP | 2.9% | |||||
| Whitmore Holdings, LLC | 8.6% | |||||
| Bradford Whitmore Trust | 8.6% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.